It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-009.mrc:55596209:4602
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:55596209:4602?format=raw

LEADER: 04602fam a2200433 a 4500
001 4050734
005 20221027024627.0
008 951107t19951995enka b 000 0 eng c
010 $a 95049885
020 $a3540760016
020 $a8876511296
035 $a(OCoLC)33817676
035 $a(OCoLC)ocm33817676
035 $9ALG2765HS
035 $a(NNC)4050734
035 $a4050734
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRC691.$bN22 1995
060 10 $aWG 500 N11 1995
082 00 $a616.1/3$220
245 00 $an-3 Fatty acids :$bprevention and treatment in vascular disease /$cedited by S.D. Kristensen [and others] ; with 38 figures and 32 tables.
260 $aLondon ;$aNew York :$bSpringer-Verlag ;$aVerona :$bBi & Gi Publishers,$c[1995], ©1995.
300 $a230 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCurrent topics in cardiovascular disease
504 $aIncludes bibliographical references.
500 $a"n-3 Fatty acids and atherosclerosis; n-3 fatty acids and ischaemic heart disease; safety, preparation, and new indications for n-3 fatty acids."
505 00 $g1.$tAn Introduction to n-3 Fatty Acids /$rE. B. Schmidt, S. D. Kristensen, S. Endres and R. De Caterina --$g2.$tLeukocyte-Endothelial Interactions and the Pathogenesis of Atherosclerosis /$rR. De Caterina and M. A. Gimbrone, Jr. --$g3.$tn-3 Fatty Acids and Atherogenesis: Effects on Leukocyte-Endothelial Interactions /$rR. De Caterina and P. Libby --$g4.$tEffect of n-3 Fatty Acids on Oxidized Low-Density Lipoprotein-Induced Leukocyte Adhesion /$rH. A. Lehr and C. Hubner --$g5.$tFish Oil: A Modulator of Experimental Atherosclerosis in Animals /$rL. K. Soei, J. M. J. Lamers, L. M. A. Sassen, A. van Tol, L. M. Scheek, D. H. W. Dekkers, J. R. van Meegen and P. D. Verdouw --$g6.$tAtherosclerosis in Arctic Populations: Autopsy Studies /$rW. P. Newman III, J. P. Middaugh, H. S. Pedersen, G. Mulvad and E. Jul --$g7.$tEvidence for Antiatherothrombotic Effects of n-3 Fatty Acids: Graft Patency after Coronary Bypass Surgery /$rH. Arnesen and J. Eritsland --
505 80 $g8.$tControl of the Cardiac Rhythm by Dietary Choices /$rJ. X. Kang and A. Leaf --$g9.$tn-3 Fatty Acids and Experimental Arrhythmogenesis /$rR. A. Riemersma --$g10.$tn-3 Fatty Acids and Ventricular Arrhythmias in Post-Myocardial Infarction Patients with a Low Ejection Fraction /$rJ. H. Christensen, P. Gustenhoff, E. Korup, J. Aaroe, E. Toft, J. Moller, K. Rasmussen, J. Dyerberg and E. B. Schmidt --$g11.$tThe Effect of n-3 Fatty Acids on the Development of Restenosis after Percutaneous Transluminal Coronary Angioplasty /$rS. D. Kristensen --$g12.$tn-3 Fatty Acids and Sudden Cardiac Death /$rT. Saldeen, R. Luostarinen and J. L. Mehta --$g13.$t[alpha]-Linolenic Acid in the Prevention of Coronary Heart Disease /$rS. Renaud --$g14.$tDietary Fish Oil in Renal Transplant Recipients Treated with Cyclosporine A: A 4-Year Follow-Up /$rJ. J. Homan Van Der Heide, H. J. M. Bilo, A. J. M. Donker and A. M. Tegzess --
505 80 $g15.$tEffects of n-3 Fatty Acids in IgA Nephropathy /$rJ. V. Donadio, Jr., B. J. Holub and E. J. Bergstrahl --$g16.$tn-3 Fatty Acids in Inflammatory Bowel Disease /$rS. Endres, E. Grottrup-Wolfers, R. Lorenz and K. Loeschke --$g17.$tDietary Marine n-3 Fatty Acids in Pregnancy in Relation to Pregnancy Outcome and Child Health and Development: a Brief Overview of Clinically Important Endpoints /$rS. F. Olsen --$g18.$tSafety Aspects of Dietary n-3 Fatty Acids /$rE. B. Schmidt, J. Moller, N. Svaneborg and J. Dyerberg --$g19.$tParenteral Administration of n-3 Fatty Acids: Indications, Experience and Perspectives /$rY. A. Carpentier, C. Simoens, V. Siderova, I. El Nakadi, M. Richelle, D. Dubois and R. J. Deckelbaum --$g20.$tBioavailability of n-3 Fatty Acid Formulations /$rJ. Dyerberg, P. Madsen, J. Moller, I. Aardestrup and E. B. Schmidt.
650 0 $aBlood-vessels$xDiseases.$0http://id.loc.gov/authorities/subjects/sh85015023
650 0 $aOmega-3 fatty acids$xTherapeutic use.
650 12 $aVascular Diseases$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D014652Q000188
650 22 $aFatty Acids, Omega-3$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D015525Q000627
650 22 $aFatty Acids, Omega-3$xpharmacology.$0https://id.nlm.nih.gov/mesh/D015525Q000494
700 1 $aKristensen, S. D.,$d1955-$0http://id.loc.gov/authorities/names/n92803459
830 0 $aCurrent topics in cardiovascular diseases.$0http://id.loc.gov/authorities/names/n88525461
852 00 $boff,hsl$hRC691$i.N22 1995